Aprogen KIC Inc (007460) - Net Assets
Based on the latest financial reports, Aprogen KIC Inc (007460) has net assets worth ₩488.30 Billion KRW (≈ $330.92 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩811.82 Billion ≈ $550.16 Million USD) and total liabilities (₩323.51 Billion ≈ $219.24 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 007460 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩488.30 Billion |
| % of Total Assets | 60.15% |
| Annual Growth Rate | 15.46% |
| 5-Year Change | -36.23% |
| 10-Year Change | N/A |
| Growth Volatility | 104.69 |
Aprogen KIC Inc - Net Assets Trend (2002–2024)
This chart illustrates how Aprogen KIC Inc's net assets have evolved over time, based on quarterly financial data. Also explore 007460 total assets for the complete picture of this company's asset base.
Annual Net Assets for Aprogen KIC Inc (2002–2024)
The table below shows the annual net assets of Aprogen KIC Inc from 2002 to 2024. For live valuation and market cap data, see 007460 company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩440.09 Billion ≈ $298.24 Million |
+5.36% |
| 2023-12-31 | ₩417.69 Billion ≈ $283.06 Million |
-9.40% |
| 2022-12-31 | ₩461.00 Billion ≈ $312.41 Million |
-34.55% |
| 2021-12-31 | ₩704.36 Billion ≈ $477.34 Million |
+2.06% |
| 2020-12-31 | ₩690.14 Billion ≈ $467.70 Million |
+30.97% |
| 2019-12-31 | ₩526.95 Billion ≈ $357.11 Million |
+169.53% |
| 2018-12-31 | ₩195.51 Billion ≈ $132.50 Million |
+30.73% |
| 2017-12-31 | ₩149.56 Billion ≈ $101.35 Million |
+323.47% |
| 2016-12-31 | ₩35.32 Billion ≈ $23.93 Million |
+584.73% |
| 2012-12-31 | ₩-7.29 Billion ≈ $-4.94 Million |
-215.33% |
| 2011-12-31 | ₩6.32 Billion ≈ $4.28 Million |
-93.88% |
| 2010-12-31 | ₩103.28 Billion ≈ $69.99 Million |
-12.51% |
| 2009-12-31 | ₩118.05 Billion ≈ $80.00 Million |
+5.17% |
| 2008-12-31 | ₩112.25 Billion ≈ $76.07 Million |
+89.55% |
| 2007-12-31 | ₩59.22 Billion ≈ $40.13 Million |
+77.67% |
| 2006-12-31 | ₩33.33 Billion ≈ $22.59 Million |
+28.29% |
| 2005-12-31 | ₩25.98 Billion ≈ $17.61 Million |
+29.94% |
| 2004-12-31 | ₩19.99 Billion ≈ $13.55 Million |
+8.77% |
| 2003-12-31 | ₩18.38 Billion ≈ $12.46 Million |
-1.28% |
| 2002-12-31 | ₩18.62 Billion ≈ $12.62 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Aprogen KIC Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 41850615408000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩577.14 Billion | 363.82% |
| Total Equity | ₩158.63 Billion | 100.00% |
Aprogen KIC Inc Competitors by Market Cap
The table below lists competitors of Aprogen KIC Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Synsam AB
ST:SYNSAM
|
$866.56 Million |
|
Five Star Bancorp
NASDAQ:FSBC
|
$866.59 Million |
|
San Bian Science & Technology Co Ltd
SHE:002112
|
$866.84 Million |
|
Hangzhou Huaguang Advanced Welding Materials Co Ltd
SHG:688379
|
$866.87 Million |
|
Smarter Microelectronics (Guangzhou) Co. Ltd. A
SHG:688512
|
$866.22 Million |
|
Viridien
PA:VIRI
|
$865.93 Million |
|
Isgec Heavy Engineering Limited
NSE:ISGEC
|
$865.93 Million |
|
Suzhou Etron Technologies Co Ltd
SHG:603380
|
$865.85 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Aprogen KIC Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 147,799,582,690 to 158,633,660,420, a change of 10,834,077,730 (7.3%).
- Net loss of 58,079,234,210 reduced equity.
- Share repurchases of 97,750 reduced equity.
- New share issuances of 761,300 increased equity.
- Other factors increased equity by 68,912,648,390.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-58.08 Billion | -36.61% |
| Share Repurchases | ₩97.75K | -0.0% |
| Share Issuances | ₩761.30K | +0.0% |
| Other Changes | ₩68.91 Billion | +43.44% |
| Total Change | ₩- | 7.33% |
Book Value vs Market Value Analysis
This analysis compares Aprogen KIC Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 7.85x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 1.46x to 7.85x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩3004.77 | ₩4392.80 | x |
| 2018-12-31 | ₩2127.44 | ₩4392.80 | x |
| 2019-12-31 | ₩1973.34 | ₩4392.80 | x |
| 2020-12-31 | ₩1744.12 | ₩4392.80 | x |
| 2021-12-31 | ₩1686.90 | ₩4392.80 | x |
| 2022-12-31 | ₩923.44 | ₩4392.80 | x |
| 2023-12-31 | ₩605.54 | ₩4392.80 | x |
| 2024-12-31 | ₩559.82 | ₩4392.80 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Aprogen KIC Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -36.61%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -38.69%
- • Asset Turnover: 0.25x
- • Equity Multiplier: 3.85x
- Recent ROE (-36.61%) is below the historical average (-11.13%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 13.38% | 3.31% | 1.09x | 3.71x | ₩628.64 Million |
| 2003 | 12.19% | 2.67% | 0.89x | 5.13x | ₩402.92 Million |
| 2004 | 9.62% | 2.07% | 0.95x | 4.91x | ₩-76.39 Million |
| 2005 | 16.57% | 3.97% | 1.02x | 4.10x | ₩1.71 Billion |
| 2006 | 20.74% | 6.54% | 0.82x | 3.86x | ₩3.58 Billion |
| 2007 | 12.08% | 5.34% | 0.81x | 2.81x | ₩1.19 Billion |
| 2008 | 8.75% | 3.57% | 0.98x | 2.51x | ₩-1.39 Billion |
| 2009 | 3.76% | 1.94% | 0.71x | 2.74x | ₩-7.30 Billion |
| 2010 | -12.40% | -5.51% | 0.68x | 3.31x | ₩-23.10 Billion |
| 2011 | -132.80% | -41.76% | 0.33x | 9.64x | ₩-51.92 Billion |
| 2012 | -30.18% | -7.07% | 0.50x | 8.56x | ₩-16.07 Billion |
| 2016 | 6.82% | 4.39% | 0.70x | 2.22x | ₩-1.12 Billion |
| 2017 | 1.57% | 5.21% | 0.17x | 1.79x | ₩-12.61 Billion |
| 2018 | -16.42% | -62.90% | 0.13x | 2.02x | ₩-51.66 Billion |
| 2019 | 3.86% | 14.97% | 0.12x | 2.16x | ₩-18.62 Billion |
| 2020 | -14.57% | -36.57% | 0.15x | 2.62x | ₩-78.40 Billion |
| 2021 | -5.36% | -12.75% | 0.17x | 2.45x | ₩-51.60 Billion |
| 2022 | -45.87% | -125.92% | 0.13x | 2.79x | ₩-120.17 Billion |
| 2023 | -37.63% | -36.94% | 0.25x | 4.02x | ₩-70.40 Billion |
| 2024 | -36.61% | -38.69% | 0.25x | 3.85x | ₩-73.94 Billion |
Industry Comparison
This section compares Aprogen KIC Inc's net assets metrics with peer companies in the Conglomerates industry.
Industry Context
- Industry: Conglomerates
- Average net assets among peers: $12,982,537,641,815
- Average return on equity (ROE) among peers: 2.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Aprogen KIC Inc (007460) | ₩488.30 Billion | 13.38% | 0.66x | $866.49 Million |
| Samyang Holdings (000070) | $3.00 Trillion | 0.94% | 0.76x | $317.93 Million |
| Doosan (000150) | $6.82 Trillion | 6.16% | 3.28x | $9.19 Billion |
| Doosan Pref Shs (000155) | $7.60 Trillion | 0.53% | 2.78x | $1.50 Billion |
| Doosan Co Ltd (000157) | $7.90 Trillion | 2.49% | 2.63x | $323.04 Million |
| Hanwha (000880) | $4.62 Trillion | 5.91% | 10.91x | $6.27 Billion |
| Hanwha Corp. Pfd. Series 1 (000885) | $33.18 Trillion | 3.54% | 4.94x | $5.70 Million |
| Hanwha Corp Preferred (00088K) | $16.95 Trillion | 2.76% | 9.00x | $657.61 Million |
| CJ Corp (001040) | $17.89 Trillion | 1.09% | 1.64x | $4.12 Billion |
| Cj Corp Pref (001045) | $16.46 Trillion | 1.67% | 1.55x | $137.94 Million |
| CJ Corp 4P Pref (00104K) | $15.40 Trillion | 0.56% | 1.60x | $548.23 Million |
About Aprogen KIC Inc
Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation syst… Read more